These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38495549)

  • 1. Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.
    Yousefian F; Smythe C; Han H; Elewski BE; Nestor M
    J Clin Aesthet Dermatol; 2024 Mar; 17(3):24-33. PubMed ID: 38495549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
    Nestor MS; Ablon G; Gade A; Han H; Fischer DL
    J Cosmet Dermatol; 2021 Dec; 20(12):3759-3781. PubMed ID: 34741573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical and device-based treatments for fungal infections of the toenails.
    Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated Perspectives on the Diagnosis and Management of Onychomycosis.
    Falotico JM; Lipner SR
    Clin Cosmet Investig Dermatol; 2022; 15():1933-1957. PubMed ID: 36133401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis in children - review on treatment and management strategies.
    Gupta AK; Venkataraman M; Shear NH; Piguet V
    J Dermatolog Treat; 2022 May; 33(3):1213-1224. PubMed ID: 32799713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of current therapies for onychomycosis.
    Ricardo JW; Lipner SR
    Expert Opin Drug Saf; 2020 Nov; 19(11):1395-1408. PubMed ID: 32990062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
    Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
    J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal Drug Use for Onychomycosis.
    Thomas J; Peterson GM; Christenson JK; Kosari S; Baby KE
    Am J Ther; 2019; 26(3):e388-e396. PubMed ID: 31082864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical efinaconazole: A sequential combination therapy with oral terbinafine for refractory tinea unguium.
    Noguchi H; Kubo M; Kashiwada-Nakamura K; Makino K; Aoi J; Fukushima S
    J Dermatol; 2021 Sep; 48(9):1401-1404. PubMed ID: 34028842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis: Rapid Evidence Review.
    Frazier WT; Santiago-Delgado ZM; Stupka KC
    Am Fam Physician; 2021 Oct; 104(4):359-367. PubMed ID: 34652111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efinaconazole and Tavaborole.
    Poulakos M; Grace Y; Machin JD; Dorval E
    J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Pulsed 1064-nm Nd:YAG Laser for the Treatment of Onychomycosis.
    Piccolo D; Kostaki D; Del Duca E; Cannarozzo G; Sannino M; Nisticò S
    Photomed Laser Surg; 2017 Apr; 35(4):213-216. PubMed ID: 28061322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-the-counter and natural remedies for onychomycosis: do they really work?
    Halteh P; Scher RK; Lipner SR
    Cutis; 2016 Nov; 98(5):E16-E25. PubMed ID: 28040821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging options in the treatment of onychomycosis.
    Elewski B; Pariser D; Rich P; Scher RK
    Semin Cutan Med Surg; 2013 Jun; 32(2 Suppl 1):S9-12. PubMed ID: 24156162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical therapy for toenail onychomycosis: an evidence-based review.
    Gupta AK; Daigle D; Foley KA
    Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
    Wang Y; Lipner SR
    Arch Dermatol Res; 2020 Oct; 312(8):581-586. PubMed ID: 32076805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for onychomycosis: new and emerging treatments.
    Lipner SR
    Expert Opin Pharmacother; 2019 Apr; 20(6):725-735. PubMed ID: 30689469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.